CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 68 enrolled
Drug / intervention
Collaborative care Plusbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04634279
NCT04634279N/ACompleted
CompareCT.gov

Competitive Revision for Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness

RAND·interventional·Posted Nov 18, 2020·Updated Aug 9, 2024

In Brief

A clinical study evaluating Collaborative care Plus for Opioid-use Disorder and 4 related conditions. Completed, enrolled 68 participants across 12 sites.

Detailed Summary

The purpose of this study is to develop and then test an enhanced version of the parent study's collaborative care intervention for co-occurring disorders (CC-COD) to reduce the risk of suicide and overdose among individuals with opioid use disorder (OUD) in combination with PTSD/depression. The parent study is CLARO, Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (NCT04559893).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpioid-use Disorder, Addiction, Depression, Post Traumatic Stress Disorder, Suicidal Ideation
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH), University of New Mexico, Boston Medical Center, Hidalgo Medical Services, First Choice Community Healthcare, Stanford University, University of Pittsburgh, Olive View-UCLA Education & Research Institute, Saint John's Cancer Institute

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 18, 2020
Enrollment StartAug 31, 2022
Primary CompletionJun 12, 2024
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.6 years ago

Interventions

Collaborative care Plusbehavioral

Collaborative care consists of a team of providers that includes a care coordinator, a primary care provider (PCP) and a behavioral health consultant (BHC), who provide evidence- and measurement-based care to a panel of patients using a clinical registry. In this model, the CC team also includes a behavioral health psychotherapist (BHP) who consults on a regular basis but does not deliver direct care. In the Collaborative Care Plus condition, the care coordinator involves family in care, teaches family about naloxone use, and provides Caring Contacts, a suicide prevention method, to patients.